The Angel Fund for ALS Research (Angel Fund, Inc.) is an independent non-profit charity (04-3478977) dedicated to supporting ALS (Lou Gehrig’s Disease) investigations at the Cecil B. Day Laboratory for Neuromuscular Research at UMass Medical School in Worcester, MA, internationally recognized for its ground-breaking work in the fight against this devastating illness.
We are not a national charity – we are local. We have very low overhead and administrative costs.
Because most have lived through the heartbreak of seeing their loved one live with ALS and lose their battle to this horrific disease.
Our mission is to support ALS (Lou Gehrig’s Disease) research and scientific investigations at the Cecil B. Day Laboratory by raising funds through events, campaigns, foundation grants and numerous other community outreach activities, to aid in finding a cause, treatment and cure for ALS.
Our offices are located in the law firm of Nigro Pettipet and Lucas, courtesy of Directors Jan and Eugene Nigro. Angel Fund President Rich Kennedy and the board members are not paid. As a result, it means we have very low overhead and administrative costs so more money goes to research. We are proud to say that 92% of funds expended goes to research.
The Harpoon 5 Miler will be held on Sunday, May 19th.
Registration for the 2019 race will open March 26th at 12 noon EST.
For more information click here.
Join us for the Jimmy Kennedy Memorial Race to Cure ALS – Squirrel Run XXII – Saturday, June 8th at Pageant Field, Merrymount Parkway in Quincy, MA.
Download the brochure here
Register now by clicking here.
Join us for the Sharon Timlin Memorial 5K Race to Cure ALS – Saturday, June 15th
www.sharontimlinrace.org
The Angel Fund for ALS Research has five amazing runners who will step off the starting line on Monday, April 15th and run 26.2 miles for The Angel Fund. These five runners have taken on the challenge to not only run the 26.2 miles, but to raise funds to help us find a treatment and […]
UMass Medical School scientists safely deliver RNAi-based gene therapy for ALS in animal model Study published in Science Translational Medicine shows ALS treatment should be safe in humans By Jim Fessenden UMass Medical School Communications October 31, 2018 Christian Mueller, PhD, and Robert H. Brown Jr., DPhil, MD Promising new research by Christian Mueller, PhD, […]
As we reflect on this past year, we have renewed hope and strength to carry forward our mission of finding a cure for ALS.
